Related Experiment Video
Updated: May 29, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
Associations Between Growth Differentiation Factor 15 and Anxiety and Depression in the General Population: The
Ragnhild Dypvik1, Katrine Kveli Fjukstad, Stian Lydersen
1From the Faculty of Medicine and Health Sciences (Dypvik) and Department of Mental Health, Faculty of Medicine and Health Sciences (Fjukstad, Lydersen), Norwegian University of Science and Technology, Trondheim; Department of Psychiatry, Levanger Hospital (Fjukstad), Nord-Trøndelag Hospital Trust, Levanger; Department of Medical Research, Bærum Hospital (Berge, Tveit), Vestre Viken Hospital Trust, Gjettum; Institute of Clinical Medicine (Tveit, Einvik) and K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine (Røsjø, Omland, Lyngbakken), Faculty of Medicine, University of Oslo, Oslo; and Division of Research and Innovation (Røsjø), Department of Cardiology, Division of Medicine (Omland, Lyngbakken), and Department of Pulmonary Medicine (Einvik), Akershus University Hospital, Lørenskog, Norway.
Objective:
Several studies suggest a bidirectional association between inflammation, and anxiety and depression. Elevated inflammatory cytokines generate and aggravate neuroinflammation, which may play a part in developing psychological symptoms. Growth differentiation factor 15 (GDF-15) is a novel biomarker possibly reflecting fibrosis and inflammation. The aim of the current study was to investigate the associations between levels of GDF-15 and symptoms of anxiety and depression in the general population.
Methods:
We measured GDF-15 in middle-aged persons participating in the Akershus Cardiac Examination 1950 Study. Symptoms of anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS), with HADS ≥8 denoting significant symptoms. We used multivariable regression analysis to assess the associations between GDF-15 and HADS, adjusting for levels of C-reactive protein (CRP), demographics, and comorbidities.
Results:
A total of 3638 participants had valid assessment of HADS and measurements of GDF-15 and CRP. The mean age was 63.9 (SD 0.65) years, and 48.8% were women. In adjusted models, levels of GDF-15 were associated with the continuous HADS-D score (β = 0.27, 95% confidence interval [CI] = 0.12 to 0.43) and HADS-D score ≥8 (odds ratio = 1.41, 95% CI = 1.12 to 1.78), but not with the continuous HADS-A score (β = 0.06, 95% CI = -0.12 to 0.24) or HADS-A score ≥8 (odds ratio = 1.06, 95% CI = 0.88 to 1.27).
Conclusions:
Levels of GDF-15 are independently associated with symptoms of depression in the general population. Our results reinforce the notion that inflammation may be a contributing factor for the development of clinical depression.
Registration:
ClinicalTrials.gov identifier NCT01555411 (Akershus Cardiac Examination [ACE] 1950 Study), https://clinicaltrials.gov/study/NCT01555411.
Related Concept Videos
Generalized Anxiety Disorder
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Social Anxiety Disorder
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Self-Discrepancy Theory
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

